Bryan Hennessy

A Novel Derivative of the Natural Agent Deguelin for Cancer Chemoprevention and Therapy

Gordon Mills, Yoo-Shin Kim, Woo-Young Kim, 2008, Cancer Prevention Research.

Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patients.

Yiling Lu, Gordon B Mills, Kevin R Coombes, 2008, Advances in experimental medicine and biology.

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

Christos Hatzis, Lajos Pusztai, Henry Kuerer, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Point mutations of protein kinases and individualised cancer therapy

Gordon B Mills, G. Mills, B. Hennessy, 2006, Expert opinion on pharmacotherapy.

Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm

Yiling Lu, Gordon B Mills, Zhenlin Ju, 2017, npj Systems Biology and Applications.

The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis

Gordon B. Mills, G. Mills, Z. Ding, 2007, Nature Cell Biology.

Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.

Gordon B Mills, G. Mills, Z. Nawaz, 2007, The Journal of clinical investigation.

Proteomic classification of breast cancer.

Gordon B Mills, Adel Tabchy, G. Mills, 2012, Current drug targets.

The biology of ovarian cancer: new opportunities for translation

Robert C. Bast, Gordon B. Mills, G. Mills, 2009, Nature Reviews Cancer.